학력 및 경력사항

• 학력사항

  • 서울대학교 의과대학 박사
  • 서울대학교 의과대학 석사
  • 서울대학교 의과대학 졸업

• 교육 및 연구경력

  • 1991-2021  : 서울아산병원 비뇨기과 전임강사, 조교수, 부교수, 교수
  • 2009-2013  : 서울아산병원 비뇨기과장
  • 2011-2015  : 아산생명과학연구원장
  • 1996  : 미국 Duke 의대 비뇨기과 연수
  • 1990-1991  : 서울아산병원 비뇨기과 전임의
  • 1983-1987  : 서울대학교병원 비뇨기과 전공의 수료

•  Hybrid ileal pouch with concomitant anti-refluxing and refluxing ureteroileal anastomosis.  BMC Urol. 2021 Jun 11;21(1):92. 
•  Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma.  N Engl J Med. 2021 Apr 8;384(14):1289-1300. 
•  Impact of positive surgical margin on biochemical recurrence in localized prostate cancer.  Prostate Int. 2021 Sep;9(3):151-156. 
•  Adjuvant Low-dose Statin Use after Radical Prostatectomy: The PRO-STAT Randomized Clinical Trial.  Clin Cancer Res. 2021 Sep 15;27(18):5004-5011. 
•  Dr. Answer AI for Prostate Cancer: Predicting Biochemical Recurrence Following Radical Prostatectomy.  Technol Cancer Res Treat. Jan-Dec 2021;20:15330338211024660. 
•  The curative effect of androgen deprivation therapy alone is insufficient in high-risk prostate cancer.  Medicine (Baltimore). 2021 Aug 6;100(31):e26833. 
•  Prostate cancer trajectory-map: clinical decision support system for prognosis management of radical prostatectomy.  Prostate Int. 2021 Mar;9(1):25-30. 
•  Association Between Sarcopenia and Survival of Patients with Organ-Confined Renal Cell Carcinoma after Radical Nephrectomy.  Ann Surg Oncol. 2021 Oct 9. 
•  Biopsy-detected Gleason grade 5 tumor is an additional prognostic factor in metastatic hormone-sensitive prostate cancer.  J Cancer Res Clin Oncol. 2021 May 4. 
•  Validation of the European association of urology biochemical recurrence risk groups after radical prostatectomy in an Asian cohort and suggestions for refinement.  Urol Oncol. 2021 May;39(5):298.e1-298.e6. 
•  Safety of autologous bone marrow-derived mesenchymal stem cells in erectile dysfunction: an open-label phase 1 clinical trial.  Cytotherapy. 2021 Oct;23(10):931-938. 
•  Efficacy and tolerability of metallic stent in patients with malignant prostatic obstruction secondary to prostatic cancer.  Low Urin Tract Symptoms. 2021 Jul;13(3):329-334. 
•  Apalutamide for patients with metastatic castrationsensitive prostate cancer in East Asia: a subgroup analysis of the TITAN trial.  Asian J Androl. 2021 Jul 13. 
•  Novel platinum bipolar electrode for irreversible electroporation in prostate cancer: preclinical study in the beagle prostate.  Sci Rep. 2021 Aug 25;11(1):17194. 
•  Impact of preoperative chemotherapy on pathologic nodal status in muscle-invasive bladder cancer: optimal lymphadenectomy in the preoperative chemotherapy era.  J Cancer Res Clin Oncol . 2021 Sep 23. 
•  Does intraoperative frozen section really predict significant positive surgical margins after robot-assisted laparoscopic prostatectomy? A retrospective study.  Asian J Androl. Jan-Feb 2021;23(1):74-79. 
•  Differential contribution of the factors determining long-term renal function after partial nephrectomy over time..  Urol Oncol. 2021 Mar;39(3):196.e15-196.e20. 
•  Noninvasive Precision Screening of Prostate Cancer by Urinary Multimarker Sensor and Artificial Intelligence Analysis.  ACS Nano. 2021 Mar 23;15(3):4054-4065. 
•  Value of clinical parameters and MRI with PI-RADS V2 in predicting seminal vesicle invasion of prostate cancer.  Scand J Urol. 2021 Feb;55(1):17-21. 
•  External Validation of the Long Short-Term Memory Artificial Neural Network-Based SCaP Survival Calculator for Prediction of Prostate Cancer Survival.  Cancer Res Treat. 2021 Apr;53(2):558-566. 
•  Width of spared neurovascular bundle after robot-assisted laparoscopic prostatectomy in patients with prostate cancer: is it a reliable factor for predicting postoperative sexual outcome?.  Prostate Int. 2021 Sep;9(3):119-124. 
•  Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer.  N Engl J Med. 2020 Jun 4;382(23):2187-2196. 
•  Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide.  N Engl J Med. 2020 Sep 0;383(11):1040-1049. 
•  Answer AI for prostate cancer: Clinical outcome prediction model and service.  PLoS One. 2020 Aug 5;15(8):e0236553.. 
•  Association of Bacillus Calmette-Guerin shortages with bladder cancer recurrence: A single-center retrospective study.  Urol Oncol. 2020 Nov;38(11):851.e11-851.e17. 
•  Epigenetic regulation of miR-29a/miR-30c/DNMT3A axis controls SOD2 and mitochondrial oxidative stress in human mesenchymal stem cells.  Redox Biol. 2020 Oct;37:101716. 
•  Phase I/IIa trial of androgen deprivation therapy, external beam radiotherapy, and stereotactic body radiotherapy boost for high-risk prostate cancer (ADEBAR).  Radiat Oncol. 2020 Oct 8;15(1):234. 
•  United in Fight against prOstate cancer (UFO) registry: first results from a large, multi-centre, prospective, longitudinal cohort study of advanced prostate cancer in Asia.  BJU Int. 2020 Apr;125(4):541-552. 
•  Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer.  N Engl J Med. 2020 Jun 4;382(23):2197-2206. 
•  Pharmacological inhibition of androgen receptor expression induces cell death in prostate cancer cells.  Cell Mol Life Sci. 2020 Jan 1. 
•  Enzalutamide in chemotherapy-naive patients with metastatic castration- resistant prostate cancer: A retrospective Korean multicenter study in a real- world setting.  Investig Clin Urol. 2020 Jan;61(1):19-27. 
•  Utility of Multiparametric Magnetic Resonance Imaging With PI-RADS, Version 2, in Patients With Prostate Cancer Eligible for Active Surveillance: Which Radiologic Characteristics Can Predict Unfavorable Disease?.  Clin Genitourin Cancer. 2020 Feb;18(1):50-55. 
•  Surgical details and renal function change after robot-assisted partial nephrectomy.  Int J Urol. 2020 May;27(5):457-462. 
•  Luteinizing Hormone Levels Relate to the Unfavorable Pathology of Prostate Cancer.  J Clin Med. 2020 Apr 29;9(5):1281. 
•  Establishment of NOAEL for intracavernous injections of human bone marrow-derived mesenchymal stem cells in rats.  Investig Clin Urol. 2020 Jan;61(1):88-98. 
•  Cause of mortality after radical prostatectomy and the impact of comorbidity in men with prostate cancer: A Multi-Institutional Study in Korea.  Cancer Res Treat. 2020 Jul 3. 
•  Does intraoperative frozen section really predict significant positive surgical margins after robot- assisted laparoscopic prostatectomy? A retrospective study.  Asian J Androl. 2020 May 1. 
•  Active learning for accuracy enhancement of semantic segmentation with CNN- corrected label curations: Evaluation on kidney segmentation in abdominal CT.  Sci Rep. 2020 Jan 15;10(1):366. 
•  Percent tumor volume vs American Joint Committee on Cancer staging system subclassification for predicting biochemical recurrence in patients with pathologic T2 prostate cancer..  J Cancer Res Clin Oncol. 2020;146(2):537-543. 
•  Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer.  N Engl J Med. 2019 Mar 28;380(13):1235-1246. 
•  Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer.  N Engl J Med. 2019 Jul 4;381(1):13-243:. 
•  Report of the third Asian Prostate Cancer study meeting Prostate Int.  Prostate Int. 2019 Jun;7(2):60-67. 
•  The small molecule WNT/β-catenin inhibitor CWP232291 blocks the growth of castration- resistant prostate cancer by activating the endoplasmic reticulum stress pathway.  J Exp Clin Cancer Res. 2019 Aug 6;38(1):342. 
•  Application of 3-D Printed Kidney Model in Partial Nephrectomy for Predicting Surgical Outcomes: A Feasibility Study.  Clin Genitourin Cancer. 2019 Oct;17(5):e878-e884. 
•  Circulating Tumor Cell Counts in Patients With Localized Prostate Cancer Including Those Under Active Surveillance.  In Vivo. 2019 Sep-Oct;33(5):1615-1620. 
•  Association of Muscle Mass with Survival after Radical Prostatectomy in Patients with Prostate Cancer.  J Urol. 2019 Sep;202(3):525-532. 
•  Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer N Engl J.  N Engl J Med. 2020 Jun 4;382(23):2197-2206. 
•  Impact of lymph node dissection in radical cystectomy for bladder cancer: How many vs how far?.  Surg Oncol. 2019 Sep;30:109-116. 
•  Prognosis of carcinoma in situ according to the presence of papillary bladder tumors after bacillus Calmette-Guérin immunotherapy.  J Cancer Res Clin Oncol. 2019 Aug;145(8):2131-2140. 
•  Time to biochemical relapse after radical prostatectomy and efficacy of salvage radiotherapy in patients with prostate cancer.  Int J Clin Oncol. 2019 Oct;24(10):1238-1246. 
•  Stratification based on adverse laboratory/pathological features for predicting overall survival in patients undergoing radical prostatectomy: A K-CaP registry-based analysis.  Medicine (Baltimore). 2019 Nov;98(45):e17931. 
•  Use of docetaxel plus androgen deprivation therapy for metastatic hormone-sensitive prostate cancer in Korean patients: A retrospective study.  Investig Clin Urol. 2019 May;60(3):195-201. 
•  Robot-assisted partial nephrectomy is associated with early recovery of renal function: Comparison of open, laparoscopic, and robot-assisted partial nephrectomy using DTPA renal scintigraphy.  J Surg Oncol. 2019 Jun;119(7):1016-1023. 
•  Development of Integrated Data and Prediction System Platform for the Localized Prostate Cancer.  Stud Health Technol Inform. 2019 Aug 21;264:1506-1507. 
•  Report of the forth Asian Prostate Cancer (A-CaP) study meeting.  Jpn J Clin Oncol. 2019 Jun 1;49(6):581-586. 
•  Adjuvant chemotherapy versus observation after radical cystectomy in patients with node-positive bladder cancer.  Sci Rep. 2019 Jun 5;9(1):8305. 
•  Clinical outcomes and costs of robotic surgery in prostate cancer: a multiinstitutional study in Korea.  Prostate Int. 2019 Mar;7(1):19-24. 
•  Induction Chemotherapy Followed by Surgery Versus Upfront Radical Cystectomy in Patients With Clinically Node-positive Muscle-invasive Bladder Cancer Clin.  Genitourin Cancer. 2019 Jun;17(3):e420-e428. 
•  Is Primary Androgen Deprivation Therapy a Suitable Option for Asian Patients With Prostate Cancer Compared With Radical Prostatectomy? J Natl Compr.  Canc Netw. 2019 May 1;17(5):441-449. 
•  Importance of androgen-deprivation therapy during enzalutamide treatment in men with metastatic castration-resistant prostate cancer following chemotherapy: results from retrospective, multicenter data Prostate Cancer Prostatic Dis.  Prostate Cancer Prostatic Dis. 2019. Mar;22(1):150-158. 
•  Percutaneous Obliteration of Urinary Leakage after Partial Nephrectomy Using N-Butyl-Cyanoacrylate Obliteration of the Urinoma with or without Coil Embolization of the Fistula Tract.  J Vasc Interv Radiol. 2019. Dec;30(12):2002-2008. 
•  pelvic irradiation in prostate cancer patients with biochemical failure following radical prostatectomy: A propensity score matching analysis.  PLoS One. 2019 Apr 11;14(4):e0215057. 
•  Vorinostat enhances gefitinib‑induced cell death through reactive oxygen species‑dependent cleavage of HSP90 and its clients in non‑small cell lung cancer with the EGFR mutation .  Oncol Rep. 2019 Jan;41(1):525-533. 
•  Simple risk assessment in prostate cancer patients treated with primary androgen deprivation therapy: The Korean Cancer Study of the Prostate risk classification .  Int J Urol. 2019. Jan;26(1):62-68. 
•  A novel histone deacetylase inhibitor, CG200745, potentiates anticancer effect of docetaxel in prostate cancer via decreasing Mcl-1 and Bcl-XL.  Invest New Drugs. 2019 Apr. 
•  Hypoxic preconditioned mesenchymal stromal cell therapy in a rat model of renal ischemia-reperfusion injury: development of optimal protocol to potentiate therapeutic efficacy.  Int J Stem Cells. 2018 Nov 30;11(2):157-167. 
•  Does epithelioid angiomyolipoma have poorer prognosis, compared with classic angiomyolipoma?.  Investig Clin Urol. 2018 Nov. 
•  Patterns of recurrence after salvage radiotherapy encompassing pelvic lymphatics in men with high-risk prostate cancer.  Anticancer Res. 2018 Nov. 
•  Effects of age and comorbidity on survival vary according to risk grouping among patients with prostate cancer treated using radical prostatectomy: A retrospective competing-risk analysis from the K-CaP registry.  Medicine (Baltimore). 2018;97(42):e12766. 
•  Prognostic factors of oncologic outcomes in metastatic chemotherapy-naïve castration-resistant prostate cancer treated with enzalutamide in actual clinical practice in East Asia.  Urol Oncol. 2018;36(9):401. 
•  Simple risk assessment in prostate cancer patients treated with primary androgen deprivation therapy: The Korean Cancer Study of the Prostate risk classification.  Int J Urol. 2019;26:62-68. 
•  Importance of androgen-deprivation therapy during enzalutamide treatment in men with metastatic castration-resistant prostate cancer following chemotherapy: results from retrospective, multicenter data.  Prostate Cancer Prostatic Dis. 2019;22(1):150-8. 
•  Prognostic Factors Related to Recurrence-Free Survival for Primary Carcinoma in situ of the Bladder after Bacillus Calmette-Guérin: A Retrospective Study.  Urol Int. 2018;101(3):269-276. 
•  In vitro, in vivo, and clinical tests of a novel flexible ureteroscope for the diagnosis and treatment of kidney and ureteral diseases.  Investig Clin Urol. 2018;59(5):328-334. 
•  Association between serum levels of insulin-like growth factor-1, bioavailable testosterone, and pathologic Gleason score.  Cancer Med. 2018;7(8):4170-4180. 
•  Declining incidence of benign lesions among small renal masses treated with surgery: Effect of diagnostic tests for characterization.  Urol Oncol. 2018;36(8):362 e9-362 e15. 
•  A deep belief network and Dempster-Shafer-based multiclassifier for the pathology stage of prostate cancer.  J Healthc Eng. 2018:4651582. 
•  Stereotactic body-radiotherapy boost dose of 18 Gy vs 21 Gy in combination with androgen-deprivation therapy and whole-pelvic radiotherapy for intermediate- or high-risk prostate cancer: a study protocol for a randomized controlled, pilot trial.  Trials. 2018 Apr 2;19(1):212. 
•  Discrimination of local recurrence after radical prostatectomy: value of diffusion-weighted magnetic resonance imaging.  Prostate Int. 2018;6(1):12-17. 
•  Androgen deprivation therapy during and after post-prostatectomy radiotherapy in patients with prostate cancer: a case control study.  BMC Cancer. 2018;18(1):271. 
•  Factors contributing to treatment outcomes of post-prostatectomy incontinence surgery for the selection of the proper surgical procedure for individual patients: A single-center experience.  Neurourol Urodyn. 2018;;37(6):1978-1987. 
•  Oncological effect of palliative transurethral resection of the prostate in patients with advanced prostate cancer: a propensity score matching study.  J Cancer Res Clin Oncol. 2018;144(4):751-758. 
•  Factors associated with testosterone recovery after androgen deprivation therapy in patients with prostate cancer.  Investig Clin Urol. 2018;59(1):18-24. 
•  Image-guided, whole-pelvic, intensity-modulated radiotherapy for biochemical recurrence following radical prostatectomy in high-risk prostate cancer patients .  PLoS One. 2018;13(1):e0190479. 
•  Combination treatment with docetaxel and histone deacetylase inhibitors downregulates androgen receptor signaling in castration-resistant prostate cancer.  Invest New Drugs. 2018;36(2):195-205. 
•  Comparison of outcomes between trimodal therapy and radical cystectomy in muscle-invasive bladder cancer: a propensity score matching analysis.  Oncotarget. 2017; 8(40):68996-69004. 
•  Downregulation of androgen receptors by NaAsO2 via inhibition of AKT-NF-kappaB and HSP90 in castration resistant prostate cancer.  The Prostate. 2017; 77(10):1128-1136 . 
•  Primary Tumor Characteristics Are Important Prognostic Factors for Sorafenib-Treated Patients with Metastatic Renal Cell Carcinoma: A Retrospective Multicenter Study .  BioMed research international . 2017; 2017:9215930 . 
•  Comparison of bone mineral loss by combined androgen block agonist versus GnRH in patients with prostate cancer: A 12 month-prospective observational study.  BioMed research international. 2017; 7:39562 . 
•  Risk of Intravesical Recurrence After Ureteroscopic Biopsy for Upper Tract Urothelial Carcinoma: Does the Location Matter? .  Journal of endourology. 2017; 31(3):259-265 . 
•  Combination of Androgen Deprivation Therapy and Salvage Radiotherapy versus Salvage Radiotherapy Alone for Recurrent Prostate Cancer after Radical Prostatectomy .  Urologia internationalis . 2017 . 
•  Changes in Weight and Metabolic Syndrome Are Associated With Prostate Growth Rate Over a 5-Year Period .  Urology . 2017; 103:185-190 . 
•  Does Ureteral Catheter Insertion Decrease the Risk of Urinary Leakage After Partial Nephrectomy in Patients With Renal Cell Carcinoma? .  Clinical genitourinary cancer . 2017; 15(4):e707-e712 . 
•  Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma .  Journal of cancer research and clinical oncology . 2017 . 
•  Neurovascular bundle size measured on 3. 0-T magnetic resonance imaging is associated with the recovery of erectile function after robot-assisted radical prostatectomy .  Urologic oncology . 2017; 35(9):542. e511-542. e517 . 
•  Preserving Renal Function through Partial Nephrectomy Depends on Tumor Complexity in T1b Renal Tumors .  Journal of Korean medical science . 2017; 32(3):495-501 . 
•  Does lymph node dissection during nephroureterectomy affect oncological outcomes in upper tract urothelial carcinoma patients without suspicious lymph node metastasis on preoperative imaging studies? .  World journal of urology . 2017; 35(4):665-673 . 
•  Combination treatment with docetaxel and histone deacetylase inhibitors downregulates androgen receptor signaling in castration-resistant prostate cancer .  Investigational new drugs . 2017 . 
•  Clinical genitourinary cancer .  Impact of Tumor Location on Local Recurrence After Nephroureterectomy for Upper Tract Urothelial Carcinoma: Implications for Adjuvant Radiotherapy . 2017; 15(2):e199-e204 . 
•  Fate of newly developed pulmonary embolism after surgery for renal cell carcinoma with vena cava thrombus .  International urology and nephrology . 2017; 49(7):1157-1163 . 
•  Is suspicious upstaging on multiparametric magnetic resonance imaging useful in improving the reliability of Prostate Cancer Research International Active Surveillance (PRIAS) criteria? Use of the K-CaP registry .  Urologic oncology . 2017; 35(7):459. e457-459. e413 . 
•  Re-Stratification of Patients with High-Risk Prostate Cancer According to the NCCN Guidelines Among Patients Who Underwent Radical Prostatectomy: An Analysis Based on the K-CaP Registry .  Cancer research and treatment : official journal of Korean Cancer Association . 2017 . 
•  Prognostic heterogeneity in T3aN0M0 renal cell carcinoma according to the site of invasion .  Urologic oncology . 2017; 35(7):458. e417-458. e422 . 
•  High throughput differential identification of TMPRSS2-ERG fusion genes in prostate cancer patient urine .  Biomaterials . 2017; 135:23-29 . 
•  Lymph node density vs. the American Joint Committee on Cancer TNM nodal staging system in node-positive bladder cancer in patients undergoing extended or super-extended pelvic lymphadenectomy .  Journal of Korean medical science. 2017; 35(4):151. e151-151. e157 . 
•  Recovery of renal function after administration of adipose-tissue-derived stromal vascular fraction in rat model of acute kidney injury induced by ischemia/reperfusion injury .  International urology and nephrology . 2017; 368(3):603-613 . 
•  Transcript Levels of Androgen Receptor Variant 7 and Ubiquitin-Conjugating Enzyme 2C in Hormone Sensitive Prostate Cancer and Castration-Resistant Prostate Cancer .  The Prostate . 2017; 77(1):60-71 . 
•  Prognostic value of vascular endothelial growth factor (VEGF), VEGF receptor 2, platelet-derived growth factor-beta (PDGF-beta), and PDGF-beta receptor expression in papillary renal cell carcinoma .  Human pathology . 2017; 61:78-89 . 
•  Pathological and oncological features of Korean prostate cancer patients eligible for active surveillance: analysis from the K-CaP registry .  Japanese journal of clinical oncology . 2017; 47(10):981-985 . 
•  Report of the Second Asian Prostate Cancer (A-CaP) Study Meeting .  Prostate international . 2017; 5(3):95-103 . 
•  Post hoc analyses of East Asian patients from the randomized placebo-controlled PREVAIL trial of enzalutamide in patients with chemotherapy-naive, metastatic castration-resistant prostate cancer .  Advanced healthcare materials . 2017; 96(27):e7223 . 
•  Self-Normalized Detection of ANXA3 from Untreated Urine of Prostate Cancer Patients without Digital Rectal Examination .  Advanced healthcare materials . 2017; 6(17) . 
•  Induction of immunoglobulin transcription factor 2 and resistance to MEK inhibitor in melanoma cells .  Oncotarget . 2017; 8(25):41387-41400 . 
•  Obesity as a Risk Factor for Unfavorable Disease in Men with Low Risk Prostate Cancer and its Relationship with Anatomical Location of Tumor .  The Journal of urology . 2017; 198(1):71-78 . 
•  Comparison of Hand-Assisted Laparoscopic vs Robot-Assisted Laparoscopic vs Open Partial Nephrectomy in Patients with T1 Renal Masses .  Journal of endourology . 2017; 31(4):374-379 . 
•  Phase III Study Comparing a Reduced Dose of Cabazitaxel (20 mg/m2) and the Currently Approved Dose (25 mg/m2) in Postdocetaxel Patients With Metastatic Castration-Resistant Prostate Cancer-PROSELICA .  Journal of clinical oncology : official journal of the American Society of Clinical Oncology . 2017; 35(28):3198-3206 . 
•  Adaptive functional change of the contralateral kidney after partial nephrectomy .  American journal of physiology Renal physiology . 2017; 313(2):F192-f198 . 
•  Prognostic Factors for Survival of Patients With Synchronous or Metachronous Brain Metastasis of Renal Cell Carcinoma .  Clinical genitourinary cancer . 2017 . 
•  Predictors of female genital organ involvement in radical cystectomy for urothelial carcinoma of the bladder: A single-center retrospective analysis of 112 female patients .  International journal of surgery (London, England) . 2017; 47:101-106 . 
•  Enzalutamide in Men with Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study .  European urology . 2017; 71(2):151-154 . 
•  Impact of metastasectomy on prognosis in patients treated with targeted therapy for metastatic renal cell carcinoma .  Journal of cancer research and clinical oncology . 2016; 142(11):2331-2338 . 
•  Bone marrow-derived mesenchymal stromal cell therapy in a rat model of cavernous nerve injury: Preclinical study for approval .  Cytotherapy . 2016; 18(7):870-880 . 
•  Comparison of renal functional outcomes in exactly matched pairs between robot-assisted partial nephrectomy using warm ischemia and open partial nephrectomy using cold ischemia using diethylene triamine penta-acetic acid renal scintigraphy .  International urology and nephrology . 2016; 48(5):687-693 . 
•  New drugs in prostate cancer .  Prostate international . 2016; 4(2):37-42 . 
•  Is lymphovascular invasion a powerful predictor for biochemical recurrence in pT3 N0 prostate cancer? Results from the K-CaP database .  Scientific reports . 2016; 6:25419 . 
•  Inhibition of EHMT2/G9a epigenetically increases the transcription of Beclin-1 via an increase in ROS and activation of NF-kappaB .  Oncotarget . 2016; 7(26):39796-39808 . 
•  Oncological outcomes of patients with incidental pathological T3a stage small renal cell carcinoma after partial nephrectomy .  Journal of cancer research and clinical oncology . 2016; 142(7):1651-1657 . 
•  Comparison of Renal Function between Robot-Assisted and Open Partial Nephrectomy as Determined by Tc 99m-DTPA Renal Scintigraphy .  Journal of Korean medical science . 2016; 31(5):743-749 . 
•  Simple renal cyst and renal dysfunction: A pilot study using dimercaptosuccinic acid renal Scan .  Nephrology (Carlton, Vic) . 2016; 21(8):687-692 . 
•  Acute Kidney Injury After Radical Cystectomy for Bladder Cancer is Associated with Chronic Kidney Disease and Mortality .  Annals of surgical oncology. 2016; 23(2):686-693 . 
•  Subclassification of high-risk clinically organ-confined prostate cancer for early cancer-specific mortality after radical prostatectomy .  Japanese journal of clinical oncology . 2016; 46(8):762-767 . 
•  Characteristics of Anteriorly Located Prostate Cancer and the Usefulness of Multiparametric Magnetic Resonance Imaging for Diagnosis .  The Journal of urology . 2016; 196(2):367-373 . 
•  Three-Dimensional Printing: Basic Principles and Applications in Medicine and Radiology .  Korean journal of radiology . 2016; 17(2):182-197 . 
•  The PREVAIL trial of enzalutamide in men with chemotherapy-naive, metastatic castration-resistant prostate cancer: Post hoc analysis of Korean patients .  Investigative and clinical urology . 2016; 57(3):174-183 . 
•  Differences in the aggressiveness of prostate cancer among Korean, Caucasian, and African American men: A retrospective cohort study of radical prostatectomy .  Urologic oncology . 2016; 34(1):3 e9-14 . 
•  Percutaneous Kidney Biopsy for a Small Renal Mass: A Critical Appraisal of Results .  The Journal of urology . 2016; 195(3):568-573 . 
•  The PREVAIL Study: Primary Outcomes by Site and Extent of Baseline Disease for Enzalutamide-treated Men with Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer .  Journal of Korean medical science . 2016; 70(4):675-683 . 
•  First-line treatment in senior adults with metastatic castration-resistant prostate cancer: A prospective international registry..  Urologic oncology. 2016; 34(5):234.e221-239. 
•  Asia prostate cancer study (A-CaP Study) launch symposium.  Prostate international. 2016; 4(3):88-96. 

• 암에 대한 모든 것

  가림출판사 |

• [한국경제TV] 전립선비대증과 감별 어려운 전립선암…PSA수치 확인해야 2023-01-07
• [한국경제TV] 육류 섭취, 1일 200g이내…토마토는 `전립선암`·올리브유는 `유방암` 도움 2022-12-27
• [헬스조선] 진단은 신속, 절제는 확실, 합병증은 최소… 전립선癌 '특화 치료' 2022-06-08
• [헬스조선] "전립선암 순하다고? 늦게 발견하면 고통 큽니다" 2022-04-18
• [넥스트데일리] 이대비뇨기병원 김청수 교수, 대한비뇨의학회 명예회장 취임 2022-04-12

• [비뇨기TV] 순한 전립선암? 늦게 발견하면 고통 크다 2022-04-25